Oncology Today with Dr Neil Love cover image

Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting with Dr Matthew Lunning

Oncology Today with Dr Neil Love

00:00

Axis Cell vs Lysos Cell

The next study is kind of a match adjusted indirect comparison of lysos cell versus axi cell for second line patients and so this is trying to align you taking the transform data and the Zuma seven data in the best statistically you know massaging way. So again you're trying to compare apples to apples but you're not flavoring the new things that we're doing for axi cell to reduce the risk of high grade CRS or high grade icons, he said.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app